Testing a new radiation plan for breast cancer that has spread to the brain
Original title: BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is given, and this is still a study, not care your own doctor can give.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a new way to give radiation to brain tumors from breast cancer.
Who this trial is for. It is for people whose breast cancer spread to the brain, who cannot have stereotactic radiotherapy. It tests a new radiation plan called DE-iPTV, given as 5 doses.
Where it stands. This trial has not reported results. The team is checking whether this radiation plan can be given as planned. They are also tracking quality of life, steroid use, and the brain spots on MRI scans. Checks happen at 8, 12, and 24 weeks. The answers are not in yet.
What this means, and what it doesn't
What it could mean: Someone who fits could ask their care team about this study. It may be worth asking about when stereotactic radiotherapy is not an option. The care team can say if it makes sense for you.
What it doesn't mean: This does not mean the new radiation plan works better. A trial is a test, not a proven treatment. Being in one is not a promise of benefit. It is not a cure.
Source: ClinicalTrials.gov, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.